Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CTH | P32929 | 1/20 | 0.33 |
| ▸ | CBS | P35520 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL157312 | 0.88 | — | — | |
| SCHEMBL10019282 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH | |
| SCHEMBL3791284 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH | |
| SCHEMBL5702814 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH | |
| SCHEMBL14660364 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH | |
| SCHEMBL21876707 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH | |
| SCHEMBL102373 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH | |
| SCHEMBL6534540 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH | |
| SCHEMBL21877046 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH | |
| SCHEMBL18244613 | 0.86 | ALDH1A1 (0.43) | ALDH1A1F2ELANETSHRCTH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236277-B2 | Process for producing nanoparticles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-08-07 | — | — | US | claimed |
| US-20100008847-A1 | PROCESS FOR PRODUCING NANOPARTICLES | 3M INNOVATIVE PROPERTIES COMPANY | 2010-01-14 | — | — | US | claimed |
| EP-2104714-A1 | PROCESS FOR PRODUCING NANOPARTICLES | 3M Innovative Properties Company (US) | 2009-09-30 | — | — | EP | claimed |
| WO-2008079800-A1 | PROCESS FOR PRODUCING NANOPARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-07-03 | — | — | WO | claimed |
| EP-2228376-B1 | PYRIPYROPENE DERIVATIVE HAVING ACAT2-INHIBITING ACTIVITY | KITASATO INST (JP) | 2015-06-03 | — | — | EP | disclosed |
| US-8519128-B2 | Pyripyropene derivatives having an ACAT2-inhibiting activity | THE KITASATO INSTITUTE (JP) | 2013-08-27 | — | — | US | disclosed |
| US-8236277-B2 | Process for producing nanoparticles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-08-07 | — | — | US | disclosed |
| US-20110184173-A1 | Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity | THE KITASATO INSTITUTE (JP) | 2011-07-28 | — | — | US | disclosed |
| EP-2228376-A1 | PYRIPYROPENE DERIVATIVE HAVING ACAT2-INHIBITING ACTIVITY | The Kitasato Institute (JP) | 2010-09-15 | — | — | EP | disclosed |
| US-20100008847-A1 | PROCESS FOR PRODUCING NANOPARTICLES | 3M INNOVATIVE PROPERTIES COMPANY | 2010-01-14 | — | — | US | disclosed |
| EP-2104714-A1 | PROCESS FOR PRODUCING NANOPARTICLES | 3M Innovative Properties Company (US) | 2009-09-30 | — | — | EP | disclosed |
| WO-2008079800-A1 | PROCESS FOR PRODUCING NANOPARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184173-A1 | Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity | ACAT2, ACAT1, AGPAT2 | ALDH1A1 1202/4885F2 1762/4885ELANE 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.